169 related articles for article (PubMed ID: 9773411)
1. Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats.
Vail DM; Moore AS; Ogilvie GK; Volk LM
J Vet Intern Med; 1998; 12(5):349-54. PubMed ID: 9773411
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of argyrophilic nucleolar organizer region (AgNOR) staining in feline intestinal lymphoma.
Rassnick KM; Mauldin GN; Moroff SD; Mauldin GE; McEntee MC; Mooney SC
J Vet Intern Med; 1999; 13(3):187-90. PubMed ID: 10357106
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age.
Jackson ML; Wood SL; Misra V; Haines DM
Can J Vet Res; 1996 Jul; 60(3):199-204. PubMed ID: 8809383
[TBL] [Abstract][Full Text] [Related]
4. Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma.
Jackson ML; Haines DM; Meric SM; Misra V
Can J Vet Res; 1993 Oct; 57(4):269-76. PubMed ID: 8269365
[TBL] [Abstract][Full Text] [Related]
5. Feline mediastinal lymphoma: a retrospective study of signalment, retroviral status, response to chemotherapy and prognostic indicators.
Fabrizio F; Calam AE; Dobson JM; Middleton SA; Murphy S; Taylor SS; Schwartz A; Stell AJ
J Feline Med Surg; 2014 Aug; 16(8):637-44. PubMed ID: 24366846
[TBL] [Abstract][Full Text] [Related]
6. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
7. Incidence of persistent viraemia and latent feline leukaemia virus infection in cats with lymphoma.
Stützer B; Simon K; Lutz H; Majzoub M; Hermanns W; Hirschberger J; Sauter-Louis C; Hartmann K
J Feline Med Surg; 2011 Feb; 13(2):81-7. PubMed ID: 21131219
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Lymphoma at Injection Sites: Pathological, Immunophenotypical, and Molecular Characterization in 17 Cats.
Roccabianca P; Avallone G; Rodriguez A; Crippa L; Lepri E; Giudice C; Caniatti M; Moore PF; Affolter VK
Vet Pathol; 2016 Jul; 53(4):823-32. PubMed ID: 26933095
[TBL] [Abstract][Full Text] [Related]
9. Changes in prevalence of progressive feline leukaemia virus infection in cats with lymphoma in Germany.
Meichner K; Kruse DB; Hirschberger J; Hartmann K
Vet Rec; 2012 Oct; 171(14):348. PubMed ID: 22915682
[TBL] [Abstract][Full Text] [Related]
10. Feline upper respiratory tract lymphoma: site, cyto-histology, phenotype, FeLV expression, and prognosis.
Santagostino SF; Mortellaro CM; Boracchi P; Avallone G; Caniatti M; Forlani A; Roccabianca P
Vet Pathol; 2015 Mar; 52(2):250-9. PubMed ID: 24903757
[TBL] [Abstract][Full Text] [Related]
11. Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases.
Essex M; Cotter SM; Hardy WD; Hess P; Jarrett W; Jarrett O; Mackey L; Laird H; Perryman L; Olsen RG; Yohn DS
J Natl Cancer Inst; 1975 Aug; 55(2):463-7. PubMed ID: 169377
[TBL] [Abstract][Full Text] [Related]
12. Feline leukaemia virus status of Australian cats with lymphosarcoma.
Gabor LJ; Jackson ML; Trask B; Malik R; Canfield PJ
Aust Vet J; 2001 Jul; 79(7):476-81. PubMed ID: 11549046
[TBL] [Abstract][Full Text] [Related]
13. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997).
Zwahlen CH; Lucroy MD; Kraegel SA; Madewell BR
J Am Vet Med Assoc; 1998 Oct; 213(8):1144-9. PubMed ID: 9787382
[TBL] [Abstract][Full Text] [Related]
14. No benefit of therapeutic vaccination in clinically healthy cats persistently infected with feline leukemia virus.
Helfer-Hungerbuehler AK; Spiri AM; Riond B; Grest P; Boretti FS; Hofmann-Lehmann R
Vaccine; 2015 Mar; 33(13):1578-85. PubMed ID: 25698488
[TBL] [Abstract][Full Text] [Related]
15. LOPH: a novel chemotherapeutic protocol for feline high-grade multicentric or mediastinal lymphoma, developed in an area endemic for feline leukemia virus.
Horta RS; Souza LM; Sena BV; Almeida IO; Jaretta TA; Pimenta MM; Reche Júnior A
J Feline Med Surg; 2021 Feb; 23(2):86-97. PubMed ID: 32684120
[TBL] [Abstract][Full Text] [Related]
16. Feline Lymphoma and a High Correlation with Feline Leukaemia Virus Infection in Brazil.
Cristo TG; Biezus G; Noronha LF; Pereira LHHS; Withoeft JA; Furlan LV; Costa LS; Traverso SD; Casagrande RA
J Comp Pathol; 2019 Jan; 166():20-28. PubMed ID: 30691602
[TBL] [Abstract][Full Text] [Related]
17. Feline lymphoma in the post-feline leukemia virus era.
Louwerens M; London CA; Pedersen NC; Lyons LA
J Vet Intern Med; 2005; 19(3):329-35. PubMed ID: 15954547
[TBL] [Abstract][Full Text] [Related]
18. Vaccine site-associated sarcoma and malignant lymphoma in cats: a report of six cases (1997-2002).
Madewell BR; Gieger TL; Pesavento PA; Kent MS
J Am Anim Hosp Assoc; 2004; 40(1):47-50. PubMed ID: 14736905
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic association between virus-negative feline leukemia and the horizontally transmitted feline leukemia virus.
Francis DP; Essex M; Cotter SM; Gutensohn N; Jakowski R; Hardy WD
Cancer Lett; 1981 Mar; 12(1-2):37-42. PubMed ID: 6268292
[TBL] [Abstract][Full Text] [Related]
20. Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression.
Patel M; Carritt K; Lane J; Jayappa H; Stahl M; Bourgeois M
Clin Vaccine Immunol; 2015 Jul; 22(7):798-805. PubMed ID: 25972402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
